Hoerter Steven L. Insider Trading Activity (CCCC)

Summary

Updated Jul 16, 2026

Hoerter Steven L. has filed 4 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $265K.

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-05-04	MBX	MBX Biosciences, Inc.	A — Grant or award	11.9K	$0.00
2025-10-20	MBX	MBX Biosciences, Inc.	P — Open-market purchase	20.0K	$13.25	$265K

Frequently Asked Questions

Who is Hoerter Steven L.?

Hoerter Steven L. is a corporate insider — currently tracked as Director of C4 Therapeutics, Inc. (CCCC). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Hoerter Steven L. submitted recently?

4 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Hoerter Steven L. been buying or selling stock?

Recorded transactions: 1 open-market purchases ($265K) and 0 open-market sales () across all tracked filings.

Where can I see all of Hoerter Steven L.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Hoerter Steven L. — SEC Form 4 Insider Trading Activity